US 9289513
Targeted cytokine for treatment of musculoskeletal diseases
granted A61KA61K38/1841A61K47/6811
Quick answer
US patent 9289513 (Targeted cytokine for treatment of musculoskeletal diseases) held by OPTION PHARMACEUTICALS, LLC expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- OPTION PHARMACEUTICALS, LLC
- Grant date
- Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/1841, A61K47/6811